Swiss National Bank
ROIV icon

Swiss National Bank’s Roivant Sciences ROIV Stock Holding History

Swiss National Bank’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3M Buy
942,246
+198,800
+27% +$5.87M 0.02% 549
2026
Q1 		$20.6M Buy
743,446
+2,800
+0.4% +$71.9K 0.01% 645
2025
Q4 		$16.1M Buy
740,646
+147,400
+25% +$2.91M 0.01% 741
2025
Q3 		$8.98M Sell
593,246
-88,400
-13% -$1.09M 0.01% 1022
2025
Q2 		$7.68M Sell
681,646
-23,500
-3% -$255K ﹤0.01% 1061
2025
Q1 		$7.11M Sell
705,146
-22,100
-3% -$239K 0.01% 1063
2024
Q4 		$8.6M Buy
727,246
+6,200
+0.9% +$73.3K 0.01% 1021
2024
Q3 		$8.32M Buy
721,046
+6,900
+1% +$78.6K 0.01% 1036
2024
Q2 		$7.55M Buy
714,146
+158,600
+29% +$1.74M 0.01% 1026
2024
Q1 		$5.86M Buy
555,546
+8,800
+2% +$94.9K ﹤0.01% 1191
2023
Q4 		$6.14M Buy
546,746
+41,000
+8% +$400K ﹤0.01% 1160
2023
Q3 		$5.91M Sell
505,746
-237,300
-32% -$2.68M ﹤0.01% 1180
2023
Q2 		$7.49M Buy
743,046
+116,800
+19% +$1.04M 0.01% 1063
2023
Q1 		$4.62M Sell
626,246
-54,100
-8% -$445K ﹤0.01% 1326
2022
Q4 		$5.44M Buy
680,346
+28,300
+4% +$157K ﹤0.01% 1270
2022
Q3 		$2.1M Hold
652,046
– – ﹤0.01% 1849
2022
Q2 		$2.65M Buy
+652,046
New +$2.59M ﹤0.01% 1718

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Swiss National Bank's ROIV Position: Q2 2026 in Review

Swiss National Bank increased its Roivant Sciences (ROIV) stake by 27% in Q2 2026, buying an estimated $5.87M and bringing the position to 942,246 shares worth $33.3M. The position accounts for 0.02% of the portfolio, ranked #549.

Swiss National Bank first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Swiss National Bank held 942,246 shares of Roivant Sciences worth $33.3M as of Q2 2026.
  • Swiss National Bank bought 198,800 Roivant Sciences shares in Q2 2026, an estimated $5.87M.
  • Roivant Sciences made up 0.02% of Swiss National Bank's portfolio in Q2 2026, its #549 holding.
  • Swiss National Bank first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.